| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 176,879 | 119,208 | 98,913 | 188,453 | | Cost of Revenue | 106,171 | 88,202 | 73,175 | 119,936 | | | Gross Profit | 70,708 | 31,006 | 25,738 | 68,517 | | | Operating Expenses | | Research Development | 37,013 | 39,341 | 36,015 | 50,856 | | Selling General and Administrative | 36,648 | 45,815 | 43,102 | 47,516 | | Non Recurring | 324 | 3,234 |
-
| 104,067 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,277) | (57,384) | (53,379) | (133,922) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (124) | 2,906 | 1,296 | 2,861 | | Earnings Before Interest And Taxes | (3,401) | (54,478) | (52,083) | (131,061) | | Interest Expense |
-
|
-
|
-
| 7,021 | | Income Before Tax | (3,401) | (54,478) | (52,083) | (138,082) | | Income Tax Expense | 625 | (4,470) | 14,309 | (7,831) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,026) | (50,008) | (66,392) | (130,251) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,026) | (50,008) | (66,392) | (130,251) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,026) | ($50,008) | ($66,392) | ($130,251) |
|
0.01% Nasdaq 
0.22%
Income Statement
